Lobby organisation
GARDP Foundation
NGO or non-profit · Health & pharma · HQ: Switzerland · Transparency Register entry
As of 7 November 2026, GARDP Foundation appears in 6 declared MEP meetings (6 different MEPs), most often with Renew Europe.
In their own words
“The Global Antibiotic R&D Partnership (GARDP) is a not-for-profit organization that works in partnership to develop new antibiotic treatments and expand access to them, specifically among the world’s most vulnerable populations. GARDP was created by WHO and DNDi in 2016 to ensure that everyone who needs antibiotics receives effective and affordable treatment, no matter where they live.”
Read the rest of the statementShow less of the statement
“We develop new treatments to manage drug-resistant bacterial infections, focusing on sexually transmitted infections, sepsis in newborns and infections in hospitalized adults and children. Our antibiotic development and access portfolio currently includes two approved treatments (cefiderocol and zoliflodacin - a novel oral treatment for treatment for gonorrhoea approved by the US FDA on 12 December 2025), and five investigational treatments (fosfomycin-amikacin, flomoxef-amikacin, fosfomycin-flomoxef, apramycin and BWC0977) for serious bacterial infections and sepsis in adults, children and newborns.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 6 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2024–2026. Bar length is relative to its busiest year (5 in 2026). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 6 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 26 Mar 2026 | Victor Negrescu | Discussion on the challenges posed by antimicrobial resistance |
| 26 Mar 2026 | Olivier Chastel | Politique de santé de l'UE |
| 26 Mar 2026 | Stine Bosse | AMR |
| 25 Mar 2026 | Aurelijus Veryga | UCPM and Future EU Strategies for Health Emergency Preparedness |
| 25 Mar 2026 | Tomislav Sokol | Health policy |
| 5 Mar 2024 | Tiemo Wölken | Revision of Pharmaceutical Package (staff level) |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.